Biotech Investment Programme

8.15 – 9.15  Registration

9.15 – 9.20  Welcome From the Conference Founder
Mattias Johansson, Director, Ezenze Ltd

9.20 – 9.40  Welcome Address
Sarah Haywood, CEO, MedCity

9.40 – 10.10  The Interview
Hakan Goker talks to Tony Kouzarides, Professor of Molecular Cancer Biology at The Gurdon Institute, University of Cambridge

10.10 – 11.20  Company Presentations
Chair: Mary Clark, Healthcare IR specialist

Elasmogen        Nanogenic Solutions         Macrophage Pharma      Biotech pharmacon         MicroQuin             Reflab

10:30 Coffee (Exhibitor area, ground floor)

11.20 – 11.40  A new Innovation Strategy at Wellcome
Lars Gredsted, Partner, Innovations Division at Wellcome Trust

11:40 – 12:00 New therapies: Precision Medicine & Neurodegenerative Disease
Baroness Prof Susan Greenfield, CEO, NeuroBio Ltd.

12.00 – 13.15  LUNCH
In the Exhibition area (ground floor). Sponsored by Precision Oncology

13.15 – 14.00 If I Knew Then What I Know Today (Panel discussion)
Moderator: Mike Ward, Global Director of Content, Informa Pharma Intelligence
Panelists: David Chiswell, Chairman Kymab; Jane Dancer, Chief Operating Officer F-star; Konstantinos Efthymiopoulos, Chairman Synaffix

14.00 – 15.00  Company Presentations
Chair: Lucy Robertshaw, Director LucyJRobertshaw

QureTech Bio         OxStem          Storm Therapeutics         ProAxsis        MGB Biopharma

15:00 Coffee (Exhibition area, ground floor)

15.10 – 15.30  Building an IP portfolio to enhance value
Ravi Srinivasan, Partner, J A Kemp

15.30 – 15.50   Nordic Overview
Lucy Robertshaw, Director LucyJRobertshaw

15.50 – 16.30  Opportunities and Challenges for new Spin-outs; a Global Perspective (Panel discussion)
Moderator: Mark Treherne, CEO Avilex Pharma, Director Talisman Therapeutics, Chairman Ubiquigent and Cyclofluidics
Panelists: Ebba Fåhraeus, CEO SmiLe Incubator; Dr Anne Lane, Executive Director UCL Business PLC; Robert Tansley, Investor Director Cambridge Innovation Capital

16.30 – 16.45  The Oncology R&D Pipeline at MSD
Khatereh Ahmadi, Executive Director, Oncology Search and Evaluation Lead, European Hub, MSD

16.45 – 17.00  Latest News on European Funding
Hakan Goker, Investment Director, Merck Ventures

17.00 – 17.15  Conclusions and Q & A

17.15 – 18.30 Afternoon Drinks Reception
Hosted by Mattias Johansson, Director, Ezenze Ltd